Home > Clinical Trials

Saved trials

TERMINATED
NCT05097599
StrataPATH™ (Precision Indications for Approved Therapies)
11 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Cancer


Advanced Solid Tumor
ACTIVE_NOT_RECRUITING
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
1,157 Enrollment(s)
284 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer; HER2-positive; Metastatic
COMPLETED
NCT04747496
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
5,000 Enrollment(s)
97 Study location(s)
OBSERVATIONAL (None)
Non-valvular Atrial Fibrillation
ACTIVE_NOT_RECRUITING
NCT04739761
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
506 Enrollment(s)
81 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer
1 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Neoplasms


Embolism
ACTIVE_NOT_RECRUITING
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
138 Enrollment(s)
37 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04538742
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
245 Enrollment(s)
72 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Metastatic Breast Cancer